{"disease":{"id":"acne-vulgaris","name":"Acne vulgaris","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":42,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"clindamycin-phosphate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin T","generic_name":"CLINDAMYCIN PHOSPHATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Lincosamide Antibacterial","quality_score":51,"revenue":null,"mechanism":"Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death."},{"drug_id":"clascoterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winlevi","generic_name":"CLASCOTERONE","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen Receptor Inhibitor [EPC]","quality_score":10,"revenue":null,"mechanism":"Winlevi works by blocking the androgen receptor, a protein that helps regulate hormones in the body."},{"drug_id":"dapsone-gel","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"dapsone gel","company_name":"Almirall, S.A.","drug_phase":"marketed","molecular_target":"","drug_class":"Sulfone [EPC]","quality_score":13,"revenue":null,"mechanism":null},{"drug_id":"fusidic-acid","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"doxycyclin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ferrous-fumarate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iron Fumarate","generic_name":"FERROUS FUMARATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":37,"revenue":null,"mechanism":""},{"drug_id":"norethisterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Micronor","generic_name":"norethisterone","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"GnRH receptors","drug_class":"Progestin","quality_score":63,"revenue":null,"mechanism":"ORIAHNN combines elagolix, which suppresses LH and FSH to reduce ovarian sex hormones, with estradiol and norethindrone acetate to mitigate side effects."},{"drug_id":"differin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"differin","company_name":"University of Magdeburg","drug_phase":"marketed","molecular_target":"Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"nicotinamide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Infuvite Adult","generic_name":"Nicotinamide","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"NAD-dependent protein deacetylase sirtuin-2","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"estradiol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estrace","generic_name":"ESTRADIOL","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":10,"revenue":null,"mechanism":"Estrace works by binding to estrogen receptors in the body, mimicking the effects of natural estrogen."},{"drug_id":"azelaic-acid","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azelex","generic_name":"AZELAIC ACID","company_name":"Leo Pharma As","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"azelaic acid","quality_score":51,"revenue":null,"mechanism":"Azelex works by inhibiting the enzyme 3-oxo-5-alpha-steroid 4-dehydrogenase 2, which is involved in the production of androgens that contribute to acne and rosacea."},{"drug_id":"clindamycin-phosphate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin T","generic_name":"CLINDAMYCIN PHOSPHATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Lincosamide Antibacterial","quality_score":51,"revenue":null,"mechanism":"Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death."},{"drug_id":"benzoyl-peroxide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"BENZOYL PEROXIDE","company_name":"Mayne Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"benzoyl peroxide","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"norethindrone-acetate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aygestin","generic_name":"NORETHINDRONE ACETATE","company_name":"Duramed Res","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Estrogen [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"sulfacetamide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klaron","generic_name":"SULFACETAMIDE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"Sulfonamide Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dapsone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aczone","generic_name":"DAPSONE","company_name":"Almirall","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6","drug_class":"Sulfone [EPC]","quality_score":65,"revenue":null,"mechanism":"Aczone works by inhibiting bacterial growth and reducing inflammation through its sulfone properties."},{"drug_id":"clindamycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cleocin","generic_name":"clindamycin","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"50S ribosomal protein L10","drug_class":"Lincosamide antibiotic","quality_score":56,"revenue":null,"mechanism":"Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage."},{"drug_id":"clascoterone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Winlevi","generic_name":"CLASCOTERONE","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen Receptor Inhibitor [EPC]","quality_score":10,"revenue":null,"mechanism":"Winlevi works by blocking the androgen receptor, a protein that helps regulate hormones in the body."},{"drug_id":"cortisone-acetate","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"adapalene","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Differin","generic_name":"ADAPALENE","company_name":"Galderma Labs Lp","drug_phase":"marketed","molecular_target":"Retinoic acid receptor beta","drug_class":"Retinoid [EPC]","quality_score":10,"revenue":null,"mechanism":"Differin works by binding to retinoic acid receptors on the skin's surface, which helps to prevent clogged pores and reduce inflammation."},{"drug_id":"ammonia","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ammonia","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"aklief","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"AKLIEF®","company_name":"Teva Pharmaceuticals USA","drug_phase":"marketed","molecular_target":"Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"erythromycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"E-Mycin","generic_name":"erythromycin","company_name":"Generic (originally Abbott/Lilly)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Bile salt export pump, Cytochrome P450 1B1","drug_class":"Macrolide [EPC]","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"nadifloxacin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nadixa","generic_name":"NADIFLOXACIN","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"nadifloxacin","quality_score":10,"revenue":null,"mechanism":"Nadixa works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication and transcription."},{"drug_id":"benzamycin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"benzamycin","company_name":"","drug_phase":"unknown","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Macrolide","quality_score":null,"revenue":null,"mechanism":"Benzamycin works by interacting with potassium channels to modulate their function."},{"drug_id":"tretinoin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"meclocycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclan","generic_name":"MECLOCYCLINE","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"","drug_class":"meclocycline","quality_score":19,"revenue":null,"mechanism":""},{"drug_id":"finacea","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Finacea","company_name":"Actavis Inc.","drug_phase":"marketed","molecular_target":"3-oxo-5-alpha-steroid 4-dehydrogenase 2","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"estrone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estron","generic_name":"ESTRONE","company_name":"Watson Labs","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"estrone","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"motretinide","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tasmadem","generic_name":"MOTRETINIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"motretinide","quality_score":null,"revenue":null,"mechanism":"Tasmadem works by inhibiting the production of sebum, a key factor in the development of acne."},{"drug_id":"hydrocortisone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ethinylestradiol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ortho-Novum 10/11-21","generic_name":"Ethinylestradiol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Estrogen","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"estring","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Estring","generic_name":"Estradiol","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Ovulation","drug_class":"Combined Oral Contraceptive (COC)","quality_score":71,"revenue":null,"mechanism":"Prevents pregnancy primarily by suppressing ovulation."},{"drug_id":"drospirenone","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Slynd","generic_name":"DROSPIRENONE","company_name":"Exeltis Usa Inc","drug_phase":"marketed","molecular_target":"Mineralocorticoid receptor","drug_class":"Progestin","quality_score":75,"revenue":null,"mechanism":"Slynd works by binding to the mineralocorticoid receptor, a protein that plays a role in hormone regulation."},{"drug_id":"sulfur","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SULFUR","company_name":"Poythress","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 1","drug_class":"sulfur","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"erythrocin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzamycin","generic_name":"Erythromycin Lactobionate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Macrolide","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"minocycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Minocycline Hydrochloride","generic_name":"MINOCYCLINE","company_name":"Rempex","drug_phase":"marketed","molecular_target":"","drug_class":"Tetracycline-class Drug","quality_score":75,"revenue":null,"mechanism":"MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"metafolin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metafolin","company_name":"University of California, San Diego","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"benoxyl","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Benoxyl","company_name":"Aier School of Ophthalmology, Central South University","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"resorcinol","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"resorcinol","company_name":"","drug_phase":"unknown","molecular_target":"Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adapalen","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adapalen","company_name":"Technische Universität Dresden","drug_phase":"marketed","molecular_target":"Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"minocyclin","indication_name":"Acne vulgaris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Minocyclin","company_name":"University of Southern California","drug_phase":"marketed","molecular_target":"30S ribosomal protein S4, 30S ribosomal protein S9, Tetracycline resistance protein, class B","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":45,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02349399","title":"Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases","phase":"","overall_status":"COMPLETED","enrollment_count":26065,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04538703","title":"Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Istanbul Medeniyet University","has_results":false},{"nct_id":"NCT00422240","title":"Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1668,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT03615768","title":"A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1617,"lead_sponsor_name":"Lee's Pharmaceutical Limited","has_results":false},{"nct_id":"NCT04538729","title":"Use of Alternative Therapy in Acne Vulgaris Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1571,"lead_sponsor_name":"Istanbul Medeniyet University","has_results":false},{"nct_id":"NCT03271021","title":"A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1488,"lead_sponsor_name":"Vyne Therapeutics Inc.","has_results":true},{"nct_id":"NCT00280657","title":"Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1326,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04134273","title":"Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03717506","title":"Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1236,"lead_sponsor_name":"Balmoral Medical company","has_results":true},{"nct_id":"NCT02566369","title":"Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1208,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04015375","title":"Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1150,"lead_sponsor_name":"Torrent Pharmaceuticals Limited","has_results":false},{"nct_id":"NCT03522441","title":"Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1125,"lead_sponsor_name":"Akorn, Inc.","has_results":true},{"nct_id":"NCT03132194","title":"Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1125,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02886715","title":"A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1110,"lead_sponsor_name":"Fougera Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT07469228","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1043,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02322866","title":"Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1034,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT04724473","title":"A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":1030,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT06733402","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT04797793","title":"A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":978,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT04883736","title":"A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":973,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02320149","title":"Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":968,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT03393494","title":"Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":825,"lead_sponsor_name":"Padagis LLC","has_results":true},{"nct_id":"NCT03168321","title":"A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":813,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT05550337","title":"Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":807,"lead_sponsor_name":"Teva Pharmaceuticals USA","has_results":true},{"nct_id":"NCT03168334","title":"A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":801,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT01445301","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06063473","title":"A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":762,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT02410031","title":"Risk Minimisation Study for Diane-35 and Its Generics","phase":"","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03028363","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT03650361","title":"Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":755,"lead_sponsor_name":"Aleor Dermaceuticals Limited","has_results":false},{"nct_id":"NCT03127956","title":"A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT03073486","title":"A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Dermira, Inc.","has_results":true},{"nct_id":"NCT01017120","title":"A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":742,"lead_sponsor_name":"Stiefel, a GSK Company","has_results":true},{"nct_id":"NCT03170388","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":741,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT02608476","title":"A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":732,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT05982613","title":"Effectiveness of Standard Therapy of Acne Vulgaris","phase":"","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT02608450","title":"A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":708,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT03433378","title":"To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT07457294","title":"1% Clascoterone Cream for the Treatment Acne Vulgaris","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":692,"lead_sponsor_name":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","has_results":false},{"nct_id":"NCT04892706","title":"Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":686,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT01320033","title":"Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":662,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT02682264","title":"An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"Cassiopea SpA","has_results":true},{"nct_id":"NCT03664739","title":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":608,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT03664752","title":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":585,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT07186413","title":"A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":561,"lead_sponsor_name":"Galderma R&D","has_results":false},{"nct_id":"NCT04321070","title":"Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":550,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03290027","title":"A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":550,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT03292640","title":"A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":547,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT06090721","title":"DMT310-009 Topical in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"Dermata Therapeutics","has_results":false},{"nct_id":"NCT02413346","title":"A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Almirall, S.A.","has_results":true}],"total":50},"guidelines":[{"drug_id":"hydrocortisone","guideline_body":"FDA label","recommendation":"temporarily relieves itching associated with minor skin irritations, inflammation, and rashes","line_of_therapy":"any","evidence_grade":"C","guideline_year":null}],"source":"Drug Landscape verified database"}